Jacek Hołub sums up 2022 in the care of patients with inflammatory bowel disease

“This year has started with very good news for us. This is what we have been striving for for many years. The Ministry of Health has lifted restrictions on the duration of biological therapy. Until now, patients with ulcerative colitis and Crohn's disease could receive treatment for one or two years. Now, the doctor decides how long the patient will receive biological treatment. This is a revolution in the treatment of our diseases - said Jacek Hołub, spokesman for the Polish Society for Supporting People with Inflammatory Bowel Disease "J-elita" in an interview with Medexpress, summarizing the year that is ending.